{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:52:50Z","timestamp":1768251170960,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T00:00:00Z","timestamp":1479254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T00:00:00Z","timestamp":1479254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Nutr"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/ejcn.2016.217","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T11:02:20Z","timestamp":1479294140000},"page":"180-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Parenteral iron polymaltose changes i:c-terminal FGF23 ratios in iron deficiency, but not in dialysis patients"],"prefix":"10.1038","volume":"71","author":[{"given":"S-J","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Satake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E R","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N D","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T D","family":"Hewitson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S G","family":"Holt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,16]]},"reference":[{"key":"BFejcn2016217_CR1","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1056\/NEJMra1401038","volume":"372","author":"C Camaschella","year":"2015","unstructured":"Camaschella C . Iron-deficiency anemia. N Engl J Med 2015; 372: 1832\u20131843.","journal-title":"N Engl J Med"},{"key":"BFejcn2016217_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","volume":"142","author":"MW Hentze","year":"2010","unstructured":"Hentze MW, Muckenthaler MU, Galy B, Camaschella C . Two to tango: regulation of Mammalian iron metabolism. Cell 2010; 142: 24\u201338.","journal-title":"Cell"},{"key":"BFejcn2016217_CR3","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69018.x","volume":"69","author":"AR Nissenson","year":"1999","unstructured":"Nissenson AR, Strobos J . Iron deficiency in patients with renal failure. Kidney Int Suppl 1999; 69: S18\u2013S21.","journal-title":"Kidney Int Suppl"},{"key":"BFejcn2016217_CR4","unstructured":"Kidney Disease: Improving Global Outcomes Anemia Work Group. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int 2012 (Suppl 2), 279\u2013335."},{"issue":"Pt 2","key":"BFejcn2016217_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1258\/acb.2008.008151","volume":"46","author":"BJ Schouten","year":"2009","unstructured":"Schouten BJ, Doogue MP, Soule SG, Hunt PJ . Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia. Ann Clin Biochem 2009; 46 (Pt 2), 167\u2013169.","journal-title":"Ann Clin Biochem"},{"key":"BFejcn2016217_CR6","doi-asserted-by":"crossref","first-page":"17291","DOI":"10.18632\/oncotarget.4174","volume":"6","author":"S Feng","year":"2015","unstructured":"Feng S, Wang J, Zhang Y, Creighton CJ, Ittmann M . FGF23 promotes prostate cancer progression. Oncotarget 2015; 6: 17291\u201317301.","journal-title":"Oncotarget"},{"key":"BFejcn2016217_CR7","doi-asserted-by":"publisher","first-page":"19647","DOI":"10.18632\/oncotarget.3794","volume":"6","author":"A Suvannasankha","year":"2015","unstructured":"Suvannasankha A, Tompkins DR, Edwards DF, Petyaykina KV, Crean CD, Fournier PG et al. FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells. Oncotarget 2015; 6: 19647\u201319660.","journal-title":"Oncotarget"},{"issue":"Pt 2","key":"BFejcn2016217_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/0004563213510708","volume":"51","author":"ER Smith","year":"2014","unstructured":"Smith ER, McMahon LP, Holt SG . Fibroblast growth factor 23. Ann Clin Biochem 2014; 51 (Pt 2), 203\u2013227.","journal-title":"Ann Clin Biochem"},{"key":"BFejcn2016217_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ki.2015.290","volume":"89","author":"V David","year":"2015","unstructured":"David V, Martin A, Isakova T, Spaulding C, Qi L, Ramirez V et al. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int 2015; 89: 135\u2013146.","journal-title":"Kidney Int"},{"key":"BFejcn2016217_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","volume":"2","author":"RJ Walton","year":"1975","unstructured":"Walton RJ, Bijvoet OL . Nomogram for derivation of renal threshold phosphate concentration. Lancet 1975; 2: 309\u2013310.","journal-title":"Lancet"},{"key":"BFejcn2016217_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0140-6736(73)93112-7","volume":"2","author":"AP Kenny","year":"1973","unstructured":"Kenny AP, Glen AC . Tests of phosphate reabsorption. Lancet 1973; 2: 158.","journal-title":"Lancet"},{"issue":"Pt 1","key":"BFejcn2016217_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1258\/0004563001901371","volume":"37","author":"JH Barth","year":"2000","unstructured":"Barth JH, Jones RG, Payne RB . Calculation of renal tubular reabsorption of phosphate: the algorithm performs better than the nomogram. Ann Clin Biochem 2000; 37 (Pt 1), 79\u201381.","journal-title":"Ann Clin Biochem"},{"key":"BFejcn2016217_CR13","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1002\/jbmr.1923","volume":"28","author":"M Wolf","year":"2013","unstructured":"Wolf M, Koch TA, Bregman DB . Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Miner Res 2013; 28: 1793\u20131803.","journal-title":"J Bone Miner Res"},{"key":"BFejcn2016217_CR14","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1210\/jc.2008-2396","volume":"94","author":"BJ Schouten","year":"2009","unstructured":"Schouten BJ, Hunt PJ, Livesey JH, Frampton CM, Soule SG . FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study. J Clin Endocrinol Metab 2009; 94: 2332\u20132337.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFejcn2016217_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1073\/pnas.0902006107","volume":"107","author":"R Goetz","year":"2010","unstructured":"Goetz R, Nakada Y, Hu MC, Kurosu H, Wang L, Nakatani T et al. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc Natl Acad Sci USA 2010; 107: 407\u2013412.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejcn2016217_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1440-1797.2006.00541.x","volume":"11","author":"P Stenvinkel","year":"2006","unstructured":"Stenvinkel P . Inflammation in end-stage renal disease: the hidden enemy. Nephrology 2006; 11: 36\u201341.","journal-title":"Nephrology"},{"key":"BFejcn2016217_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1744-9987.2011.01037.x","volume":"16","author":"T Hryszko","year":"2012","unstructured":"Hryszko T, Rydzewska-Rosolowska A, Brzosko S, Koc-Zorawska E, Mysliwiec M . Low molecular weight iron dextran increases fibroblast growth factor-23 concentration, together with parathyroid hormone decrease in hemodialyzed patients. Ther Apher Dial 2012; 16: 146\u2013151.","journal-title":"Ther Apher Dial"},{"key":"BFejcn2016217_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1159\/000327019","volume":"33","author":"Y Takeda","year":"2011","unstructured":"Takeda Y, Komaba H, Goto S, Fujii H, Umezu M, Hasegawa H et al. Effect of intravenous saccharated ferric oxide on serum FGF23 and mineral metabolism in hemodialysis patients. Am J Nephrol 2011; 33: 421\u2013426.","journal-title":"Am J Nephrol"},{"key":"BFejcn2016217_CR19","doi-asserted-by":"publisher","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","volume":"108","author":"EG Farrow","year":"2011","unstructured":"Farrow EG, Yu X, Summers LJ, Davis SI, Fleet JC, Allen MR et al. Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc Natl Acad Sci USA 2011; 108: E1146\u2013E1155.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejcn2016217_CR20","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1172\/JCI31370","volume":"117","author":"C Peyssonnaux","year":"2007","unstructured":"Peyssonnaux C, Zinkernagel AS, Schuepbach RA, Rankin E, Vaulont S, Haase VH et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest 2007; 117: 1926\u20131932.","journal-title":"J Clin Invest"},{"key":"BFejcn2016217_CR21","first-page":"1764","volume":"63","author":"HJ Knowles","year":"2003","unstructured":"Knowles HJ, Raval RR, Harris AL, Ratcliffe PJ . Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res 2003; 63: 1764\u20131768.","journal-title":"Cancer Res"},{"key":"BFejcn2016217_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/1471-2369-14-281","volume":"14","author":"E Gravesen","year":"2013","unstructured":"Gravesen E, Hofman-Bang J, Mace ML, Lewin E, Olgaard K . High dose intravenous iron, mineral homeostasis and intact FGF23 in normal and uremic rats. BMC Nephrol 2013; 14: 281.","journal-title":"BMC Nephrol"},{"issue":"Suppl 2","key":"BFejcn2016217_CR23","first-page":"S93","volume":"15","author":"B Danielson","year":"2004","unstructured":"Danielson B . Structure, Chemistry, and Pharmacokinetics of Intravenous Iron Agents. J Am Soc Nephrol 2004; 15 (Suppl 2), S93\u2013S98.","journal-title":"J Am Soc Nephrol"},{"key":"BFejcn2016217_CR24","doi-asserted-by":"publisher","first-page":"473514","DOI":"10.1155\/2012\/473514","volume":"2012","author":"R Dillon","year":"2012","unstructured":"Dillon R, Momoh I, Francis Y, Cameron L, Harrison CN, Radia D . Comparative efficacy of three forms of parenteral iron. J Blood Transfus 2012; 2012: 473514.","journal-title":"J Blood Transfus"},{"key":"BFejcn2016217_CR25","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1210\/jc.2012-1811","volume":"97","author":"ER Smith","year":"2012","unstructured":"Smith ER, Cai MM, McMahon LP, Holt SG . Biological variability of plasma intact and C-terminal FGF23 measurements. J Clin Endocrinol Metab 2012; 97: 3357\u20133365.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ejcn2016217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ejcn2016217","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ejcn2016217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T13:42:42Z","timestamp":1648215762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejcn2016217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,16]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["BFejcn2016217"],"URL":"https:\/\/doi.org\/10.1038\/ejcn.2016.217","relation":{},"ISSN":["0954-3007","1476-5640"],"issn-type":[{"value":"0954-3007","type":"print"},{"value":"1476-5640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,16]]},"assertion":[{"value":"2 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}